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Available online 2 October 2013Abstract The purpose of this study was to isolate cancer stem cells (CSCs, also called tumor-initiating cells, TICs) from
established human colorectal carcinoma (CRC) cell lines, characterize them extensively and dissect the mechanism for their
stemness. Freshly isolated CD44+ and CD44− cells from the HCT-15 human colon cancer cell line were subjected to various
analyses. Interestingly, CD44+ cells exhibited higher soft agar colony-forming ability and in vivo tumorigenicity than CD44−
cells. In addition, the significant upregulation of the protein Snail and the downregulation of miR-203, a stemness inhibitor, in
CD44+ cells suggested that this population possessed higher invasion/metastasis and differentiation potential than CD44− cells.
By manipulating the expression of CD44 in HCT-15 and HCT-116 cells, we found that the levels of several EMT activators and
miR-203 were positively and negatively correlated with those of CD44, respectively. Further analyses revealed that miR-203
levels were repressed by Snail, which was shown to bind to specific E-box(es) present in the miR-203 promoter. In agreement,
silencing miR-203 expression in wild-type HCT-116 human colon cancer cells also resulted in an increase of their stemness.
Finally, we discovered that c-Src kinase activity was required for the downregulation of miR-203 in HCT-15 cells, which was
stimulated by the interaction between hyaluronan (HA) and CD44.
Taken together, CD44 is a critical molecule for modulating stemness in CSCs. More importantly, we show for the first time
that the downregulation of miR-203 by HA/CD44 signaling is the main reason for stemness-maintenance in colon cancer cells.
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87miR-203 suppression in colon cancer stemnessIntroductionStem cells have critical roles not only in the maintenance of
organ homeostasis but also in the development of tumors
(Jordan et al., 2006). Recent findings confirm the idea that
cells with stem cell properties are truly responsible for
tumorigenesis (Dean et al., 2005). These stem cell-like
cancer cells (also termed cancer stem cells, CSCs) have been
defined as a subset of tumor cells with the ability to
self-renew and give rise to phenotypically diverse tumor cell
populations to drive tumorigenesis. Not surprisingly, CSCs
have been identified in a wide variety of cancers thus far
(Clevers, 2011).
Although, colorectal CSCs (Co-CSCs) were originally
identified as a small group of CD133+ cells present in the
primary tumors which exhibited high tumorigenicity in
immunodeficient mice (O'Brien et al., 2007; Ricci-Vitiani et
al., 2007), some studies have shown that CD44+ colorectal
cancer cells also possess stem-like properties (Dalerba et al.,
2007). Interestingly, accumulating evidence demonstrates
that CD44 is not only a marker for Co-CSCs but also of
functional importance in cancer initiation (Chu et al., 2009;
Du et al., 2008). In addition, a recent study has also shown
that direct repression of CD44 could inhibit tumor formation
in prostate cancers (Liu et al., 2011). These results clearly
indicate that CD44 plays a critical role in determining the
tumorigenic capacity of certain types of cancers. However,
the underlying mechanism of cancer initiation mediated by
CD44 in Co-CSCs is poorly understood.
Snail is well-known for its roles in embryonic develop-
ment and cancer progression (Barrallo-Gimeno and Nieto,
2005). The transcriptional regulation by this factor often
involves the recognition and binding of this factor to the
consensus core sequence (-CANNTG-) located in the promot-
er region of its target genes (Cano et al., 2000). It has been
reported that normal mammary epithelial cells could be
induced to adopt the CD44high/CD24low expression profile
that is associated with certain attributes of stem cells when
the transcription factors Snail or Twist were conditionally
overexpressed in these cells (Mani et al., 2008). Elevated
Snail expression not only enhanced drug resistance by
antagonizing p53-mediated apoptosis but also enhanced
the acquisition of stemness in ovarian cancer cells (Kurrey
et al., 2009). In addition, Snail promotes the expression of
IL-8 and other genes to induce stem-like activities in
colorectal cancer cells (Hwang et al., 2011). Collectively,
the above findings strongly suggest that Snail, Twist or ZEB1
may be sufficient to induce a population with the charac-
teristics of cancer stem cells.
MicroRNAs (miRNAs) are small non-coding RNAs that
regulate gene expression in a post-transcriptional manner
(He and Hannon, 2004). In addition to playing roles in
regulating cell proliferation, differentiation, apoptosis and
immunity, other functions of miRNAs are currently being
extensively examined. Among these studies, the association of
miRNAs with the formation, angiogenesis, metastasis and
chemoresistance of tumors has become one of the core issues
in the epigenetic study of cancer. In fact, many reports have
shown the important roles of miRNAs in the development of
various cancers as well as in the self-renewal and differenti-
ation of embryonic and tissue-specific stem cells (Calin andCroce, 2006). Interestingly, it has recently been reported that
the expression of certain miRNAs involved in cancer stemness
is modulated by EMT (epithelial–mesenchymal transition)
activators such as ZEB1 and Twist via the regulation of their
promoter activities (Bourguignon et al., 2010; Wellner et al.,
2009). These findings suggest a different mechanism by which
these factors influence CSCs. Additionally, ample evidence
indicates the involvement of various miRNAs in different
signaling pathways leading to colorectal cancer (Liu and Chen,
2010). For example, miR-451 has been shown to negatively
regulate the self-renewal capability and tumorigenicity of
Co-CSCs by suppressing COX-2-mediated Wnt activation
(Bitarte et al., 2011). In addition, miR-21 has been shown to
play an important role in regulating the stemness of colon
cancer cells by modulating TGFβR2 signaling (Yu et al., 2012).
Although miR-203 was originally characterized as a skin-
specific microRNA that promotes the differentiation of
epidermal cells by repressing stemness (Yi et al., 2008), it
was reported recently that it is not only functioning as a
tumor-suppressor in hepatocellular carcinoma (Furuta et al.,
2010) but also inhibiting the proliferation, migration and
invasiveness in prostate cancer cells (Viticchie et al., 2011).
Moreover, restoration of miR-203 expression reverses the
chemoresistance in p53-mutated colon cancer cells (Li et al.,
2011). It appeared that miR-203 downregulates the prolifer-
ation of epithelial precursor cells and self-renewal of stem
cells by directly targeting p63 and Bmi1, respectively (Lena et
al., 2008; Wellner et al., 2009). Nevertheless, the role of
miR-203 in tumor initiation in Co-CSC has not yet been
delineated.
In this study, we first demonstrated that the CD44+
population isolated from the HCT-15 human colon cancer
cell line not only exhibited multiple in vitro features of CSCs
but also showed higher in vivo tumorigenicity. In accor-
dance, knocking down CD44 expression in HCT-15 cells
resulted in reduced soft agar colony-forming ability and the
decreased expression of Bmi1, Snail and Twist1, whereas
the increased expression of Snail, Twist1 as well as several
ESC markers was found in CD44-overexpressing cells. We
further showed that CD44 plays crucial roles in cancer
initiation and stemness-maintenance in HCT-15 and HCT-116
cells which are modulated by the Snail-mediated suppression
of a stemness inhibitor, miR-203. Finally, we further demon-
strated that c-Src kinase, which is activated by hyaluronan
(HA)/CD44 signaling, is responsible for Snail upregulation in
these cells. Collectively, our results show for the first time
that CD44 not only can be a singlemarker used for the isolation
of CSCs from human colon cancer lines but also acts as a signal
transducer leading to the suppression of miR-203. This
suppression is crucial for the maintenance of stemness in
these Co-CSCs.
Materials and methods
Cell culture
Human colon carcinoma cell lines (HCT-15, HCT-116 and
HT-29) were purchased from the American Type Culture
Collection (ATCC). While three parental cell lines were
maintained in RPMI-1640 medium supplemented with 10%
fetal calf serum (Biological Industries, USA), 100 units/ml
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B (Biological Industries, USA) at 37 °C in 5% CO2, several stable
transfectants derived from HCT-15, HCT-116 and HT-29
cells were maintained under similar conditions except that
5 μg/ml of puromycin was added to the media. To assess the
effects of the hyaluronan (HA, Sigma, USA)–CD44 interaction,
cells were cultured on HA (100 μg/ml)-coated or -noncoated
dishes for 24 h, followed by treating without or with 10 μM
PP2 or 2 μM Dasatinib (Sigma, USA) for another 24 h before
being harvested.
Magnetic cell separation and fluorescence-activated
cell sorting (FACS)
Dissociated HCT-15 or HCT-116 cells were suspended in
regular medium and 1 × 107 cells were then labeled by
microbead-conjugated CD44 antibody. Cells were then mag-
netically separated using a CD44 Cell Isolation Kit (Miltenyi
Biotec, Germany). A positive selection column was used to
collect the CD44-positive (CD44+) cells. In the meantime,
fluorescence-activated cell sorting was used to identify and
select CD44+ HCT-15 and HT-29 cells after they were
incubatedwith a FITC-conjugated CD44 antibody. The isolated
CD44+ and CD44-negative (CD44−) cells were used for the
following experiments.
Xenograft
Cells (1 × 105, 1 × 104 or 1 × 103) were resuspended in 50 μl
PBS (phosphate buffered saline) and mixed with an equal
volume of Matrigel (BD) before being injected subcutane-
ously into 8-week-old nude mice (BALB/c strain, obtained
from the National Laboratory Animal Center). Tumor size
was measured every week with calipers, and the tumor
volume was calculated using the formula (length × width2)/
2.
Chromatin immunoprecipitation
ChIP assays were performed following the protocol provided
by Upstate Biotechnology to investigate whether Snail binds in
situ to the E-boxes present in the miR-203 promoter and
whether such binding is affected by the CD44 signaling
triggered by HA treatment. Parental or CD44+ HCT-15 cells
were cultured on dishes coated with or without HA in the
presence or absence of PP2 for 24 h. Cells were then fixed
with 1% formaldehyde for 15 min, followed by a 5-min
treatment with 1.25 M glycine to quench the reaction.
Nuclear extracts were prepared as described previously
(Schreiber et al., 1989) and were then sonicated to shear
DNA into 500-bp fragments. Precleared lysates were subjected
to overnight immunoprecipitation with 2 μg/ml of rabbit
anti-Snail antibody or normal rabbit IgG (negative control).
DNA samples were recovered after phenol/chloroform extrac-
tion and isopropanol precipitation. A volume equal to that of
the final precipitate was used for PCR amplification with
primers (sense: 5′-TGGCTCCAGACTTGGGGCAA-3′ and anti-
sense: 5′-GGTAGCCCCGTACCTGCCTC-3′) that gave rise to a
miR-203 promoter region amplicon containing a putative
E-box.Additional methods
Detailed methods for the soft agar colony forming assay,
transwell migration assays, reporter assay, real-time RT-PCR
and Western blotting analysis can be found in the Supple-
mentary data section.
Results
CD44+ HCT-15 cells display stem cell properties
both in vitro and in vivo
Because CD44 has been shown to be a robust marker for
isolating colorectal CSCs (Co-CSCs) from patient tumors
(Du et al., 2008), we first examined whether CD44+ cells
isolated from the HCT-15 human colon cancer line have
more prominent stem cell properties. Both CD44+ and
CD44− subgroups were present in the parental HCT-15
cells, and the former subset was estimated to be 10% of the
total population according to our flow cytometric analysis
(Supplementary Fig. 1A). Magnetic separation was then
applied to purify the CD44+ and CD44− populations and the
RNA and protein levels of CD44 were analyzed by qRT-PCR
and Western blotting, respectively. As expected, CD44
RNA and protein levels were significantly higher in CD44+
cells than in CD44− cells (Supplementary Fig. 1B and 1C).
Because anchorage-independent growth and the migra-
tion ability of cancer cells have been shown to correlate
well with their in vivo capacity for tumorigenesis and me
tastasis, respectively (Shin et al., 1975), isolated CD44+
and CD44− cells were subjected to soft agar colony-
forming and transwell migration assays. Our results de-
monstrated that CD44+ cells exhibited higher clonoge-
nicity in soft agar and higher migration ability than their
CD44− counterparts (Figs. 1A and B). However, a similar
proliferative ability of CD44+ and CD44− cells was
observed according to their respective growth curve
(Supplementary Fig. 1D).
To investigate whether CD44+ HCT-15 cells were stem-
like cells, qRT-PCR was performed to analyze several typical
markers for embryonic stem cells (ESCs) including Oct4,
Sox2, Nanog, Klf4 and Lin28. The data showed that the
expression of the ESC markers was significantly increased in
CD44+ cells as was the intestinal stem cell marker, Lgr5
(Fig. 1C). On the other hand, we found that CD44− HCT-15
cells expressed higher RNA levels of markers for differenti-
ated colonic epithelial cells (e.g., CK20 and CDX1) than
CD44+ cells. However, the respective expression levels of
the markers for endocrine cells (CHGA) and goblet cells
(mucin) did not differ between the two populations
(Fig. 1D). To demonstrate that CD44+ HCT-15 cells could
differentiate into mature cancer cells, freshly isolated
CD44+ cells were maintained in a complete medium for
2 weeks. Treatment with fetal calf serum (FCS) resulted in
marked increases of the mRNA levels for both CK20 and CDX1
in a time-dependant manner (Figs. 1E and F). Since a recent
study has shown that the introduction of Snail or Twist
stimulates cultured mammary cancer cells to adopt CSC
characteristics (Mani et al., 2008), therefore besides Oct4
and Sox2, the levels of Snail and Slug in CD44+ and CD44−
HCT-15 cells were also analyzed by Western blotting. As seen
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two EMT activators were found in CD44+ cells which were
accompanied by a dramatic decrease in E-cadherin levels.
However, no apparent morphological differences could be
detected in the two subpopulations derived from HCT-15
cells (data not shown), suggesting that these alterations did
not lead to EMT.
To further assess whether CD44+ HCT-15 cells had the
most critical feature of CSCs, high tumorigenicity in the
immunodeficient animals, we subcutaneously injected
equal numbers of CD44+ and CD44− cells (mixed with
Matrigel) into nude mice. Animals injected with 1 × 104
and 1 × 103 CD44+ cells (Figs. 1H and I) grew visible tumors
respectively at 2 and 4–5 weeks after transplantation, but
only two mice receiving 1 × 104 CD44− cells grew visible
tumor after 6 weeks. A much higher incidence of tumor
growth was also observed in CD44+ cells (Table 1). By
contrast, CD133+ HCT-15 cells did not show any advantage
over CD133− cells or the parental cells with regard to tumor
formation in nude mice (Supplementary Fig. 2A and B).
Based on these data, we concluded that a small group of
CD44+ (but not CD133+) HCT-15 cells that form tumors with
high efficiency after xenograft represents the cancer stem
cell population.CD44 is required to maintain stem-like properties
Recent studies have indicated that CD44 is not only a
marker for Co-CSCs but also a critical factor for cancer
initiation (Chu et al., 2009; Du et al., 2008). Hence,
several stable CD44-knockdowned clones were established
by expressing CD44 shRNA via lentiviral infection of
HCT-15 cells. Real-time RT-PCR assay was performed to
confirm the downregulation of CD44 in the transfectants.
CD44 levels in clones 2 and 4 were decreased to 60% and
50%, respectively, relative to sh-GFP, a negative control
clone (Supplementary Fig. 3A). We next performed a soft
agar colony-forming assay to examine whether CD44 levels
affect the anchorage-independent growth of these cells.
As expected, the numbers of colonies generated from
clones 2 and 4 were dramatically decreased in comparison
to the control group (Fig. 2A). In the meantime, we also
noticed that few colonies in the soft agar were grown from
both CD44− cells and CD44-knockdowned clones and we
wondered whether CD44 levels in these colonies were
altered. After flow cytometric analysis, significant in-
creases of CD44 levels were detected in cells collected
respectively from the aforementioned colonies (Supplementa-
ry Fig. 4). These results strongly suggested that colon cancer
cells, regardless of their origins, exhibited higher anchorage-
independent growth abilities if they expressed higher levels of
CD44.
Because Nanog, Bmi1, Snail and Twist1 have been shown
to be involved in self-renewal, tumor progression, and
metastasis, we asked whether their levels were affected by
CD44 downregulation. To no surprise, marked decreases in
the protein levels of these four factors were found in
CD44-knockdowned clones (Fig. 2B).
In the meantime, stable CD44-overexpressing clones
(S1 and S2) were also established from HCT-15 cells via
retroviral infection. Quantitative RT-PCR and Westernblotting confirmed that CD44 levels were much higher in
the CD44-overexpressing compared to the cells infected
with the viruses carrying the vector alone (Supplementary
Fig. 3B and C). Contrary to the clones, the numbers of
colonies generated from S1 and S2 were significantly
higher than the control group (Fig. 2C). Additionally,
immunoblotting demonstrated that the nuclear levels of
Snail and Twist1 were significantly increased in CD44-
overexpressing transfectants when compared with the
vector control cells (Fig. 2D). In accordance with the above
results, qRT-PCR results showed that the expression levels
of several pluripotency factors of ES cells including Oct4,
Sox2, Nanog and Klf4 were significantly increased in S1 and
S2 cells (Fig. 2E). Collectively, these data suggested that
CD44 plays important roles in maintaining some of the CSC
properties of HCT-15 cells possibly by upregulating several
ESC markers.
CD44 and miR-203 expression levels are inversely
correlated in HCT-15 and HCT-116 cells
MicroRNAs (miRNAs), a class of highly conserved small RNA
molecules that regulate gene expression, have been
reported as modulators of pathogenesis in various types of
cancers (Vazquez-Ortiz et al., 2006). It is well documented
that miR-200 family members are crucial modulators of
EMT, metastasis and stemness (Wellner et al., 2009). We
therefore examined whether miR-200 family members were
differentially expressed in CD44+ versus CD44− HCT-15 cells.
Our data showed that the expression of miR-183, miR-200b
and miR-203 was significantly decreased in CD44+ cells
(Fig. 3A). Subsequently, a time-dependent increase in the
expression of miR-203 was observed after FCS treatment in
CD44+ HCT-15 cells (Fig. 3B). In addition, only miR-203
expression levels (not miR-183, miR-200a and miR-200b)
were consistent in two different CD44-knockdowned clones
(Supplementary Fig. 5A–C). We therefore chose miR-203 as
a candidate for the following studies. To first elucidate the
relationship between CD44 and miR-203 expression, qRT-PCR
was performed to analyze miR-203 levels in CD44-knockdowned
and -overexpressing clones. Our results showed that the
expression of miR-203, a stemness inhibitor, was increased
significantly in CD44-knockdowned clones generated from
HCT-15 as well as HCT-116 cells (Fig. 3C). Conversely, miR-203
expression was markedly decreased in CD44-overexpressing
clones derived from both lines (Fig. 3D). Together, these results
suggested that the stemness of HCT-15 and possibly HCT-116
cells might be modulated by miR-203, whose expression in two
CRC lines seemed to be negatively regulated by CD44.
Involvement of Snail in theHA/CD44 signaling-mediated
downregulation of miR-203
To further assess whether the downregulation of miR-203 in
CD44+ HCT-15 cells is directly affected by CD44 signaling,
hyaluronan (HA), a natural ligand for CD44 as well as a major
component of the extracellular matrix, was used to trigger
the signaling of this receptor. Parental HCT-15 cells were
cultured on dishes coated without or with HA (100 μg/ml)
for 24 hours (h), followed by treatment with or without
10 μM PP2 (an inhibitor of the c-Src family kinases) or 2 μM
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Table 1 Incidence of tumor growth.
Subpopulation Cell numbers injected
105 104 103
CD44+ 10/10 10/10 4/5
CD44− 4/10 3/10 ND
Note: Higher incidence of tumor growth was observed in CD44+
cells. ND means “not determined”.
91miR-203 suppression in colon cancer stemnessDasatinib (a specific inhibitor for c-Src kinase), for another
24 h. While the miR-203 levels in HCT-15 cells were
significantly decreased by incubating the cells with HA,
this reduction could be fully restored by the addition of PP2
or Dasatinib (Fig. 4A), suggesting that c-Src is the mediator
of the HA/CD44 signaling that downregulates miR-203
expression in these cells. In addition, HA treatment could
also stimulate the expression of several EMT activators
(Fig. 4B) as well as the nuclear accumulation of Snail protein
(Fig. 4C). Because Snail has been shown to repress miR-203
expression (and vice versa) in MCF-7 human breast cancer
cells (Moes et al., 2012), we examined whether Snail had a
similar effect in HCT-15 cells. Indeed, a drastic downregulation
of miR-203 was found in a Snail-overexpressing stable clone
generated from HCT-15 cells (Fig. 4D). The abovementioned
observations strongly suggest that miR-203 downregulation,
triggered by the HA/CD44 interaction in HCT-15 cells, is likely
through a c-Src-stimulated Snail expression and/or its nuclear
accumulation.
Direct binding of Snail to the E-box elements of the
miR-203 promoter in HCT-15 cells
Recent studies have indicated that an EMT-activator ZEB1,
promotes the stemness-maintenance of cancer stem cells by
suppressing stemness-inhibitory microRNAs by downregu-
lating the activities of their promoters (Wellner et al.,
2009). Several predicted E-box elements are located up-
stream of the transcription start site of miR-203 (Fig. 5A), a
stemness inhibitor. To determine whether Snail directly
regulates the expression of miR-203, two luciferase reporter
constructs driven by either a wild-type or an E-box-mutated
miR-203 promoter were transfected with or without a
Snail-overexpressing vector into 293T cells. Our reporterFigure 1 CD44+ HCT-15 cells display some stem-like properties.
parental, CD44+ and CD44− HCT-15 cells on 0.6% agarose at 1 × 104 c
were stained with crystal violet and counted under a microscope. (B
analyzed by transwell migration assay. Cells (5 × 104) were seeded in
the lower surface of the filters were stained with crystal violet and t
to analyze the RNA levels of several typical markers of embryonic st
cells (Lgr5) (C) or differentiated colonic cells (CK20, CDX1, CHGA an
cultivated in medium containing 10% FBS for 0, 7 and 14 days before
(F) genes in undifferentiated and differentiated CD44+ cells was analy
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compared with the tumors grown from the CD44− cells. The tumor
transplanted with 1 × 104 CD44+ (left in upper panel, H) or CD44− (righassays showed that Snail suppressed the activity of the
wild-type miR-203 promoter more efficiently than that of
the E-box mutant promoter (Fig. 5B), further supporting the
theory that the E-box is crucial for Snail-mediated repression
of miR-203 promoter activity. To examine whether Snail
interacts in situ with the E-box elements in the promoter
region of miR-203, chromatin immunoprecipitation (ChIP)
assays were performed in the CD44+ subpopulation of HCT-15
cells using an anti-Snail antibody. Our results showed that PCR
amplification using the anti-Snail-mediated precipitates from
CD44+ cells as the template and a pair of oligonucleotide
primers specific for the miR-203 promoter region containing
an E-box gave rise to a specific amplicon with an expression
level that was much higher than those derived from CD44−
cells (Fig. 5C). The above results were subsequently verified
by qPCR analysis (Fig. 5D). Next, we asked whether the
interaction between Snail and the E-box element on miR-203
promoter was affected by HA/CD44 signaling. CD44+ HCT-15
cells were cultured on dishes coated with or without HA for
24 h, followed by the treatment with or without PP2 for
another 24 h. ChIP results clearly showed that the binding of
Snail to the E-box element in the miR-203 promoter was
markedly increased when cells were grown on HA-coated
dishes. Interestingly, this interaction appeared to be
significantly reduced by the addition of PP2 (Fig. 5E),
reiterating the fact that c-Src kinase activity is crucial for
HA/CD44-modulated miR-203 expression. More significant
differences between treatments could be observed when
qPCR was applied (Fig. 5F). These results verify that the HA/
CD44 interaction enhances the direct binding of Snail to the
promoter region of miR-203. Collectively, our data strongly
suggest that Snail negatively regulates miR-203 expression
by binding directly to the E-box of its promoter following
HA/CD44 interaction.MiR-203 functions as a stemness-inhibitor in HCT-15,
HT-29 and HCT-116 cells
To further investigate the effects of miR-203 on Co-CSC
properties, stable clones derived from HCT-15 and HT-29 cells
overexpressing this microRNA (M1 and M2) were selected after
retroviral infection. Interestingly, the CD44+ population was
markedly decreased in miR-203-overexpressing clones
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Figure 2 CD44 levels affect several stem-like properties in HCT-15 cells. Two stable transfectants (clones 2 and 4) and one
control clone (sh-GFP) were established by expressing CD44 and GFP shRNAs, respectively, via the lentiviral infection of HCT-15
cells. (A) Cells (1 × 104/well) from sh-GFP and clones 2 and 4 were each seeded on 0.6% agarose in a six-well plate. Two weeks later,
crystal violet staining was performed and the number of colonies was counted by microscopy. (B) Whole cell lysates prepared from the
aforementioned three clones were subjected to Western blotting with antibodies against the indicated proteins. CD44-overexpressing
clones (S1 and S2) and the vector-control clone (V) derived from HCT-15 cells were generated as described in Materials and methods.
(C) Soft agar colony formation abilities of the CD44-overexpressing S1 and S2 clones derived from HCT-15 cells. (D) Nuclear Snail and
Twist1 expression levels were analyzed by Western blotting. (E) Total RNAs were extracted from clones S1 and S2 and the vector
control cells. Real-time RT-PCR was performed to measure the mRNA levels of the indicated genes. Data representing the mean ± SD
of three independent experiments were analyzed by t-test (*P b 0.05).
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93miR-203 suppression in colon cancer stemnesssoft agar and spheroids were also dramatically reduced in
miR-203-overexpressing transfectants (Figs. 6B and C). To
examine the effect of miR-203 upregulation on the in vivotumorigenesis of Co-CSCs, CD44+ HCT-15 cells infected
without or with retro-miR-203 were transplanted into nude
mice as described above and tumor growth was monitored. As
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94 S.-Y. Ju et al.can be seen, both tumor incidence and growth rate of these
cells were significantly diminished by miR-203 upregulation
(Fig. 6D). In the meantime, we wanted to know whether the
stemness of Co-CSCs could be enhanced by knocking down
miR-203 expression. Because of the extremely low transfec-
tion efficiency (regardless of the reagents used) observed in
HCT-15 cells and the fact that a variety of Co-CSC properties
found in CD44+ HCT-15 cells were also detected in CD44+
HCT-116 cells (Supplementary Fig. 6), CD44+ HCT-116 cells
were used to analyze the effects of the transient knockdown
of miR-203 on the stemness of human colon cancer cells. To no
surprise, after introducing a miR-203 antagomir into HCT-116
cells, protein levels of markers such as CD44, ALDH, Nanog andSox2 were markedly increased (Fig. 6E). In addition, spheroids
generated in defined medium from the miR-203 antagomir-
transfected HCT-116 cells were more resistant to differenti-
ation (i.e., cell spreading) induced by 1% FCS (Fig. 6F). Taken
together, these results suggest that the Co-CSC properties of
HCT-15, HT-29 and HCT-116 cells are greatly affected by
miR-203.Discussion
High tumorigenicity has been found in a minor cell population
present in a wide variety of primary tumors as well as
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95miR-203 suppression in colon cancer stemnessestablished tumor cell lines. These so-called cancer stem cells
(CSCs) or tumor-initiating cells (TICs) can be isolated and/or
enriched by using specific surface and/or intracellular
markers, serum-free culturing, and dye exclusion methods.
However, neither a common method nor a universal marker is
currently available for identifying such a population from all
cancers.CD133 has been used to identify various normal stem cells
and CSCs. In fact, two recently published reports describe
the isolation of colon cancer stem cells (Co-CSCs) using
CD133 as a marker. The first publication showed that a small
proportion (1 in 262) of CD133+ cells from primary colon
cancers has a much higher tumorigenic potential in immu-
nodeficient mice (Ricci-Vitiani et al., 2007). In addition to
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97miR-203 suppression in colon cancer stemnessreporting a similar finding in vivo, the other study also
demonstrated that CD133+ cells isolated from primary
tumors formed spheres and could be maintained in an
undifferentiated state in serum-free conditions (O'Brien et
al., 2007). Although CD133+ cells isolated from the HCT-15
human colon cancer line had a higher colony-forming ability
than both the parental and CD133− cells (data not shown),
they did not exhibit higher in vivo tumorigenicity after being
cultivated in a defined medium for one month (Supplemen-
tary Fig. 2A and B). One possible explanation for this finding
is that the purified CD133+ cells may gradually lose their
stemness, and therefore their tumorigenicity, when cultured
in a serum-free medium supplemented with EGF, bFGF and
N2.
Recent studies also demonstrated that Co-CSCs could be
isolated using CD44 as a single selection marker (Chu et al.,
2009; Du et al., 2008). On the other hand, an earlier work
showed that the EpCAMhigh/CD44+/CD166+ cells are Co-CSCs
(Dalerba et al., 2007). In support of the observations made
by Chu and Du, we found that freshly isolated CD44+ HCT-15
cells exhibited a much higher soft agar colony-forming ability
and tumor growth after xenograft than their CD44− counter-
parts (Fig. 1). These findings indicated that CD44 is a better
marker than CD133 for selecting a stem cell-like population
from HCT-15 cells. Although CD44 had been previously shown
to participate in a wide variety of cellular functions including
lymphocyte activation, recirculation and homing, hematopoi-
esis, and tumor metastasis (Misra et al., 2011), the functional
aspects of this molecule in generating and/or maintaining
CSCs have not yet been explored extensively.
Accumulating evidence has shown that CD44 is not only a
marker for Co-CSCs but also a critical factor for cancer
initiation (Du et al., 2008). Interestingly, a recent study
demonstrated that the induction of EMT stimulates cultured
breast cells to adopt stem cell characteristics (Mani et al.,
2008). Notably, our CD44 knockdown (Figs. 2A and B) and
overexpression experiments (Figs. 2C and D) demonstrated
that CD44 is important for maintaining the CSC properties of
HCT-15 cells by regulating the EMT activators including
Bmi1, Twist and Snail. However, the precise roles of Bmi1
and Twist in establishing and/or maintaining the stemness of
CD44+ HCT-15 cells remain to be elucidated.Figure 6 The upregulated expression of miR-203 in HCT-15 and
transient knockdown of miR-203 expression results in appearance of
and miR-203-overexpressing stable clones (M1 and 2) derived from H
The percentage of CD44+ population was quantified by flow cytometr
carried out using clones derived from HCT-15 and HT-29 cells. After c
counted respectively using Colony 1.1 software. (D) Purified CD44+ H
miR-203 retroviruses. Forty-eight hours after puromycin selectio
individually, with Matrigel and then injected subcutaneously into nud
weekly basis and data indicate the mean tumor size ± SD of tumors p
the vector-control clone. The tumors shown were collected
miR-203-overexpressing (right in the upper panel) or vector-control
from HCT-116 cells after they were transfected respectively with th
blotting was performed to examine the levels of the indicated protei
probes. (F) Spheroids derived from the GFP-expressing HCT-116 ce
ctrl-miR (a, b) or the miR-203 antagomir (c, d) and cultured in media
under a fluorescent microscope (400×) and the differentiation of thMicroRNAs (miRNAs) are small non-coding RNAs which
regulate gene expression in a post-transcriptional manner. A
recent study reported that ZEB1, another EMT activator, can
directly suppress the transcription of miR-141, miR-200c, and
miR-203 by interacting with their respective promoter regions.
Moreover, miR-200c, miR-203 and miR-183 cooperate to
suppress the expression of polycomb repressor Bmi1 which
plays a role in maintaining the stemness of cancer cells and
mouse embryonic stem (ES) cells (Wellner et al., 2009). Another
report has shown that hyaluronan (HA)/CD44 interaction can
activate c-Srcwhich subsequently stimulates the transcriptional
activity of Twist to promote miR-10b production, leading to
tumor progression (Bourguignon et al., 2010). Our results
demonstrated that miR-203 was significantly decreased in
freshly isolated CD44+ HCT-15 and HCT-116 cells (Figs. 3A and
Supplementary 6C). Consistently, miR-203 levels were dramat-
ically decreased in CD44-overexpressing transfectants (Fig. 3D)
and were increased in CD44-knockdowned clones (Fig. 3C)
generated from the aforementioned two cell lines. Therefore,
CD44 might play a critical role in regulating miR-203 expression
in Co-CSCs.
As described above, hyaluronan (HA) is a component of
the extracellular matrix of mammalian cells that specifi-
cally interacts with its receptor, CD44, to activate c-Src-
dependent signaling. This c-Src signaling promotes cell
migration and tumor progression (Taher et al., 1996).
According to our results, HA treatment triggered a decrease
in miR-203 levels (Fig. 4A) as well as increases in total Snail
protein and its nuclear accumulation (Fig. 4C) in CD44+
HCT-15 cells. In addition, a drastic reduction in miR-203
expression was found in a Snail-overexpressing clone (Fig. 4D).
Together, these findings suggest that Snail is responsible for
the HA/CD44-mediated downregulation of miR-203 and such a
speculation was also supported by our ChIP results, which
clearly showed a direct interaction between Snail and the
E-box-containing region of the miR-203 promoter (Fig. 5).
Indeed, Snail-mediated repression of miR-203 has recently
been reported in other types of cancer cells (Moes et al., 2012;
Wellner et al., 2009). In fact, a double-negative miR-203/Snail
feedback loop has been proposed in breast cancer cells because
a mesenchymal-to-epithelial transition (MET) was observed
in these cells as a result of the miR-203-mediatedHT-29 cells abolishes some of their Co-CSC properties, and the
some SC characteristics in HCT-116 cells. (A) The vector-control
CT-15 and HT-29 cells were established by retroviral infection.
y. (B) Soft agar colony-formation assay or (C) sphere culture was
rystal violet staining, the numbers of colonies or spheroids were
CT-15 cells were infected with either the control (vector-ctrl) or
n, equal numbers of cells (1 × 104) from each were mixed,
e mice (n = 10 for each type). Tumor growth was monitored on a
er group. *P b 0.05 when compared with the tumors grown from
from animals 8 weeks after they were transplanted with
cells (left in the upper panel). (E) Total lysates were prepared
e miR-203 antagomir or control miR (ctrl-miR) for 48 h. Western
ns using antibodies against CD44, ALDH, Nanog, Sox2 and Snail as
lls cultured in a defined medium were transfected with 5 nM
containing 1% FCS. Twenty-four hours later, pictures were taken
e spheroid cells was estimated by the extent of their spreading.
CD44+cells CD44-cells
Figure 7 A proposed model for the maintenance of stemness of HCT-15 and HCT-116 human colon cancer cells by HA/CD44
signaling. Initially, HA interacts with CD44, resulting in c-Src activation, which in turn upregulates Snail expression. Subsequently, the
increased Snail molecules translocate into the nucleus and bind with the E-box elements of the miR-203 promoter, hence repressing
its expression. Once the expression of this microRNA was markedly reduced, not only was the expression of several stemness markers
elevated but also certain stemness properties (i.e., self-renewal and anchorage-independent growth) were greatly increased, leading
to a superior tumor initiation potential.
98 S.-Y. Ju et al.suppression of Snail (Moes et al., 2012). It will be interesting
to examine whether this type of loop operates in CD44+
HCT-15 cells and to identify the downstream targets of
miR-203 responsible for maintaining the stemness of the
aforementioned cell population.
Several studies have demonstrated that the expression
of Snail could be regulated by both transcriptional and post-
transcriptional mechanisms. For example, the TGFβ/Smad
and TNFα/NF-κB pathways transcriptionally induce Snailexpression via direct binding of the activated factors to the
Snail promoter (Barbera et al., 2004; Vincent et al., 2009). On
the other hand, receptor tyrosine kinase signaling by mole-
cules such as fibroblast growth factor (FGF) and epidermal
growth factor (EGF) increases Snail stability by suppressing the
activity of GSK-3β (De Craene et al., 2005). Even though our
results suggest the involvement of c-Src in Snail-mediated
downregulation of miR-203 triggered by the HA/CD44 inter-
action (Figs. 5C and D), the precise mechanism responsible for
99miR-203 suppression in colon cancer stemnessthe activation of Snail by HA/CD44 signaling remains to be
investigated.
In conclusion, CD44 seems to be a better marker than
CD133 for isolating stem cell-like population from both HCT-15
and HCT-116 cells. In addition, the functional importance of
this molecule for stemness maintenance (e.g., increased
spheroid and soft agar colony formation, upregulation of
stem cell marker genes and downregulation of the stemness
inhibitory miRNAs) of Co-CSCs derived from HCT-15 cells has
been demonstrated (Fig. 7). We will next dissect the detailed
CD44 signaling pathway responsible for establishing the
stemness of CRC cells. Understanding this pathway will help
to clarify the involvement of CD44 signaling, EMT inducers
and microRNAs in a complicated network that leads to the
development of Co-CSCs.
Appendix A. Supplementary data
Supplementary data to this article can be found online at
http://dx.doi.org/10.1016/j.scr.2013.09.011.
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